Cargando…
Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3
BACKGROUND: Spinocerebellar ataxia type 3 (SCA3) is the most common subtype of autosomal dominantly inherited spinocerebellar ataxias (SCAs). No validated blood biomarker is available to assess either disease progression or therapeutic response. Neurofilament light chain (NfL) was recently proposed...
Autores principales: | Li, Quan-Fu, Dong, Yi, Yang, Lu, Xie, Juan-Juan, Ma, Yin, Du, Yi-Chu, Cheng, Hao-Ling, Ni, Wang, Wu, Zhi-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829913/ https://www.ncbi.nlm.nih.gov/pubmed/31684998 http://dx.doi.org/10.1186/s13024-019-0338-0 |
Ejemplares similares
-
Serum neurofilament light chain as a severity marker for spinocerebellar ataxia
por: Shin, Hye-Rim, et al.
Publicado: (2021) -
Tau and neurofilament light‐chain as fluid biomarkers in spinocerebellar ataxia type 3
por: Garcia‐Moreno, Hector, et al.
Publicado: (2022) -
Association of the Level of Neurofilament Light With Disease Severity in Patients With Spinocerebellar Ataxia Type 2
por: Yang, Lu, et al.
Publicado: (2021) -
Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia
por: Donath, H., et al.
Publicado: (2021) -
The Role of Serum Levels of Neurofilament Light (NfL) Chain as a Biomarker in Friedreich Ataxia
por: Frempong, Bernice, et al.
Publicado: (2021)